November 9-13, 2010                                                   Marriott Marquis, New York City

2009 FACULTY

Sylvia Adams, MD, Assistant Professor, NYU Cancer Center, New York, NY

Sanjiv S. Agarwala, MD Section Chief of Hematology/Oncology, St. Luke’s Hospital & Health Network, Bethlehem, PA

James P. Allison, PhD Director, Ludwig Center for Cancer Immunotherapy, Chair, Immunology Program, David H. Koch Chair of Immunological Studies, Attending Immunologist, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY

Edward P. Ambinder, MD Associate Chairman and Program Director, Chemotherapy Foundation Symposium and Clinical Professor of Medicine, Mount Sinai School of Medicine, New York, NY

Kenneth Anderson MD Kraft Family Professor of Medicine, Chief Division of Hematologic Neoplasia, Director Lipper Myeloma Center and Lebow Institute for Myeloma Therapeutics, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA

Anne Angiolillo, MD Associate Professor of Pediatrics, Children’s National Medical Center, George Washington University School of Medicine, Washington, DC 

Joseph S. Bailes, MD Partner, Texas Oncology, Austin, TX

Charles M. Balch, MD, FACS Professor of Surgery and Oncology and Dermatology, Deputy Director, Johns Hopkins Institute for Clinical and Translational Research, Baltimore, MD

Jacques Banchereau, PhD Director, Baylor Institute for Immunology Research, Max and Gayle Clampitt Chair for Immunology Research, Dallas, TX

Pierre Band, MD, FRCPC, Health Canada

Chandra P. Belani, MD Miriam Beckner Professor of Medicine, Penn State Cancer Institute, Deputy Director, Penn State Cancer Institute, Hershey, PA

Johanna Bendell, MD Director, GI Oncology Research, Associate Director, Drug Development Unit, Sarah Cannon Research Institute, Nashville, TN

James R. Berenson, MD Chief Executive Officer and President, Medical and Scientific Director, Institute for Myeloma and Bone Cancer Research, West Hollywood, CA

Jordan D. Berlin, MD Associate Professor of Medicine, Clinical Director, GI Oncology Program, Vanderbilt-Ingram Cancer Center, Nashville, TN

Charles D. Blanke, MD Systemic Therapy Provincial Program Leader,
Head, Division of Medical Oncology, B.C. Cancer Agency, University of British Columbia, Vancouver, Canada

Archie Bleyer, MD Clinical Research Professor, Medical Director Clinical Research, Cancer Treatment Center, St. Charles Medical Center, Bend, Oregon

George R. Blumenschein, MD Associate Professor of Medicine, Thoracic/ Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Marcia S. Brose MD, PhD Assistant Professor, Abramson Cancer Center, Department of Otolaryngology, Head & Neck Surgery, Department of Medicine, Division of Hematology/Oncology, Department of Dermatology, University of Pennsylvania, Philadelphia, PA

Kenneth H. Buetow, PhD, Associate Director for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD

Steven J. Burakoff, MD Professor of Medicine, Professor of Oncological Sciences, Director of Mount Sinai Cancer Institute, New York, NY

Howard A. Burris, MD Chief Medical Officer, Director of Drug Development, The Sarah Cannon Cancer Center, Nashville, TN

Harold J. Burstein,  MD, PhD  Assistant Professor of Medicine, Department of Medical Oncology, Solid Tumor Oncology, Assistant Professor, Department of Breast Oncology, Dana-Farber Cancer Institute, Boston, MA

Hilary Calvert, MD Professor of Medicine, Newcastle University, School of Clinical and Laboratory Sciences, Newcastle upon Tyne, United Kingdom

Emily Chan, MD, PhD Assistant Professor of Medicine, Vanderbilt University Medical Center, Nashville, TN

Gurkamal S. Chatta, MD Visiting Associate Professor of Medicine, Interim Co-Director of the Prostate and Urologic Cancer Program, University of Pittsburgh, Hillman Cancer Center, Pittsburgh, PA

Sant P. Chawla, MD Director, International Institute of Clinical Studies, Sarcoma Oncology Center, Santa Monica, CA

Bruce D. Cheson, MD Professor of Medicine, Head of Hematology, Division of Hematology / Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC

Carmel Cohen, MD Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Mount Sinai Medical Center, New York, NY

Deirdre J. Cohen, MD Assistant Professor of Medicine, Division of GI Oncology, NYU Cancer Center, New York, NY

Seymour Cohen, MD Associate Clinical Professor of Medicine, Mount Sinai School of Medicine, New York, NY

Jorge E. Cortes, MD Professor of Medicine, Leukemia, MD Anderson Cancer Center, Houston, TX

Walter J. Curran, Jr., MD Professor and Chairman, Department of Radiation Oncology, Emory School of Medicine, Chief Medical Officer, Emory Winship Cancer Institute, Atlanta, GA

Janet Cuttner, MD Professor of Medicine and Neoplastic Diseases, Division of Hematology Oncology, Mount Sinai School of Medicine, New York, NY

Myron S. Czuczman, MD Chief, Lymphoma / Myeloma Service, Associate Professor of Medicine, Roswell Park Cancer Institute, Buffalo, NY

Gustavo Del Toro, MD Associate Professor, Director, Pediatric Hematopoietic Cell Transplantation Service, Jack Martin Division of Pediatric Hematology/Oncology, Mount Sinai School of Medicine, New York, NY

Alexis Demopoulos, MD Mount Sinai School of Medicine, Derald H. Ruttenberg Treatment Center, New York, NY

Susan F. Dent, MD, Bsc, FRCPC Associate Professor of Medicine, Ottawa Hospital Cancer Centre, , University of Ottawa, Canada

David Dix, MD British Columbia’s Children’s Hospital, Vancouver, British Columbia, Canada

Don S. Dizon, MD, FACP Director of Medial Oncology, Medical Director, Integrative Care Program, Co-Director, Center for Sexuality, Intimacy and
Fertility, Women & Infants' Hospital, Providence, RI

Jessica S. Donington, MD Assistant Professor of Cardiothoracic Surgery, NYU School of Medicine, New York, NY

Ira Dunkel, MD, Pediatric Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY

Merrill J. Egorin, MD, FACP Professor of Medicine and Pharmacology, University of Pittsburgh Cancer Institute, Pittsburgh, PA

Harry P. Erba, MD, PhD Associate Professor, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

Eric J. Feldman, MD Director of Hematological Malignancies, Weill-Cornell Medical College, Attending Physician, New York-Presbyterian Hospital, New York, NY

Conrad Fernandez, MD IWK Health Centre, Halifax, Nova Scotia, Canada

Alessandra Ferrajoli, MD Associate Professor, Leukemia Department, University of Texas M.D. Anderson Cancer Center, Houston, TX

Anna C. Ferrari, MD Associate Professor of Oncology, Co-Director, Genitourinary Cancer Program, NYU Cancer Center, New York, NY

Jonathan W. Friedberg, MD Associate Professor of Medicine and Oncology, Chief, Hematology/Oncology Division, James P Wilmot Cancer Center, University of Rochester, Rochester, NY

Janice L. Gabrilove, MD The James F. Holland Professor of Medicine, Vice Chair, Clinical Research, The Department of Medicine, Director, Experimental Therapeutics, Division of Hematology/Oncology, Director, K30 Clinical Research Training Program (CRTP), Co-Director, Masters in Clinical Research, The Mount Sinai School of Medicine, New York, NY

Sergio A. Giralt, MD Professor, Stem Cell Transplantation, Professor, Lymphoma/Myeloma, Disease Site Liaison, International Center, Ofc/EVP, Physician-in-Chief, Deputy Chair, Stem Cell Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX

William J. Gradishar, MD, FACP Professor of Medicine, Division of Hematology and Medical Oncology, Department of Medicine, Feinberg School of Medicine at Northwestern University, Director of Breast Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Naomi B. Haas, MD Associate Professor of Medicine, Abramson Cancer Center, Director, Prostate and Renal Programs, Department of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA

Heine Hansen, MD, FRPC Professor, The Finsen Center, Department of Oncology, The National University Hospital of Copenhagen, Denmark

Carolyn Hartley, President, CEO, Physicians EHR, Inc., Cary, NC

Thomas Herzog, MD Professor of Clinical Obstetrics and Gynecology, Department of Clinical Obstetrics and Gynecology, Columbia University Medical Center, New York, NY

Celestia Higano, MD Professor, Department of Medicine, Director of the Genitourinary Oncology Clinical Research Group, Division of Oncology, University of Washington, Seattle, WA

Howard S. Hochster, MD Professor of Medicine and Clinical Pharmacology, NYU Cancer Institute, New York, NY

Paulo M. Hoff, MD FACP Chairman of Medical Oncology, Instituto do Cancer de Sao Paulo Otavio Frias de Oliveira, University of Sao Paulo, Executive Director, Centro de Oncologia, Hospital Sirio Libanes, Brazil

Ronald Hoffman, MD Professor, Medicine, Hematology and Medical Oncology, Professor Gene and Cell Medicine, Mount Sinai School Of Medicine, New York, NY

Anne Hurlet, MD Associate Professor Pediatrics, Hematology/Oncology, Mount Sinai School of Medicine, New York, NY

Thomas E. Hutson, DO, PharmD, FACP Director, GU Oncology Program,
Texas Oncology, PA, Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX

Robert Iannone, MD Adjunct Assistant Professor of Pediatrics, Children's Hospital of Philadelphia and the University of Pennsylvania, PA

Jeffrey Infante, MD Associate Director, Drug Development, Sarah Cannon Cancer Center, Nashville, TN

Steven H. Itzkowitz, MD Professor of Medicine, Associate Director of The Dr. Henry D. Janowitz Division of Gastroenterology, Director of the GI Fellowship Program at Mount Sinai School of Medicine, New York, NY

Hagop M. Kantarjian, MD Professor of Medicine, Internist, Department of Leukemia, University of Texas MD Anderson Cancer Center, Chairman & Professor, Leukemia Department, MD Anderson Cancer Center, Houston, TX

Prashant Kapoor, MD Division of Hematology, Mayo Clinic, Rochester, MN

Corey J. Langer, MD Professor of Medicine, Hematology-Oncology Division, Abramson Cancer Center of the University of Pennsylvania, Department of Medical Oncology, Medical Director Thoracic Oncology, Director of Research, Fox Chase Cancer Center, Philadelphia, PA

John P. Leonard, MD Associate Professor of Medicine, Clinical Director, Center for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY

Allan Lipton, MD Professor of Medicine and Oncology, Medicine-Division of Hematology Oncology, M.S. Hershey Medical Center, Hershey, PA

Patricia LoRusso, MD Professor of Medicine, Wayne State University
Medical Director, Phase I Clinical Trials, Karmanos Cancer Institute, Detroit, MI

Peter Manley, MD Dana-Farber Cancer Institute and Children’s Hospital Cancer Center, Boston, MA

Ursula Matulonis, MD, Director/Program Leader, Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, Boston, MA

William P. McGuire, MD Professor of Medicine and Oncology, Director, Weinberg Cancer Institute, Georgetown University, Baltimore, MD

Kathy D. Miller, MD Associate Professor, Department of Medicine,
School of Medicine, Associate Director for Clinical Research, Indiana University Simon Cancer Center, Indianapolis, IN

Alain Mita, MD Staff Physician, Clinical Investigator, Department of Medicine, Division of Medical Oncology, Cancer Therapy and Research Center, Assistant Professor of Medicine, University of Texas Science Center San Antonio, San Antonio, TX

Anne Kirstine Moller, MD Department of Oncology, Rigshospitalet – Copenhagen University Hospital, Copenhagen, DENMARK

Franco Muggia, MD, Cogan Professor of Oncology, NYU Cancer Institute, New York, NY

William K. Oh, MD Professor of Medicine and Urology, Ezra M. Greenspan Professor of Clinical Cancer Therapeutics, Director of the Division of Hematology and Medical Oncology, Co-Director of the Prostate Cancer Program, and Associate Director for Clinical Research for The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY

Cynthia R. Osborne, MD Medical Oncologist, Texas Oncology, Baylor Charles A. Sammons Cancer Center, Dallas, TX

Iman Osman, MD Associate Professor of Dermatology and Urology, Director, Interdisciplinary Melanoma Cooperative Program, Joan and Joel Smilow Research Center, New York University Langone Medical Center, New York, NY

Roman Perez-Soler, MD Gutman Professor of Medicine, Chairman, Department of Medical Oncology, Montefiore Medical Center, Bronx, NY

Daniel P. Petrylak, MD Associate Professor of Medicine, Director, Genitourinary Cancer Program, Director, Prostate Cancer Program, Herbert Irving Cancer Center, Columbia University Medical Center, New York, NY

Arnaud Pigneux, MD Service des Maladies du Sang, Centre François Magendie, Bordeaux, France

Suresh S. Ramalingam, MD Associate Professor, Chief of Thoracic Medical Oncology, Emory University School of Medicine, Emory Winship Cancer Institute, Atlanta, GA

Ramesh K. Ramanathan, MD Medical Director, TGen Clinical Research Service at Scottsdale Health Care, Clinical Professor of Medicine, University of Arizona, College of Medicine, Phoenix, AZ

Kanti R. Rai, MD Chief, Division of Hematology/Oncology, Long Island Jewish Medical Center, Joel Finkelstein Cancer Foundation Professor of Medicine, Albert Einstein College of Medicine, New York, NY

George Raptis, MD Associate Professor Medicine, Hematology and Medical Oncology, Associate Professor, Obstetrics, Gynecology and Reproductive Science, Mount Sinai School of Medicine, New York, NY

Susan R. Rheingold, MD Attending Physician, Children’s Hospital of Philadelphia, PA

Gregory J. Riely, MD Associate Attending, Thoracic Oncology Service, Division of Solid Tumor, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Gail J. Roboz, MD Assistant Professor of Medicine, Director, Leukemia Program, Medicine, Hematology and Oncology, Weill Medical College of Cornell University, New York, NY

Carlos Rodriguez-Galindo, MD Associate Professor of Pediatrics, Director, Pediatric Solid Tumor Program, Dana-Farber Cancer Institute and Children's Hospital, Boston, MA

Tamar Safra, MD Medical Staff, Oncology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Andrew Seidman, MD Associate Attending Physician, Memorial Sloan Kettering Cancer Center, New York, NY

Manish A. Shah, MD Attending Physician, Memorial Hospital, Associate Professor, Weill-Cornell Medical Center, Assistant Member, Memorial Sloan-Kettering Cancer Center, New York, NY

Lawrence N. Shulman, MD Chief Medical Officer and Senior VP for Medical Affairs, Chief, Division of General Oncology, Dana-Farber Cancer Institute, Boston, MA

Richard T. Silver, MD, FACP Professor of Medicine, Weill Cornell Medical College, Attending Physician, Department of Medicine, Division of Hematology and Medical Oncology, Cornell University, New York, NY

Lewis Silverman, MD Associate Professor, Medicine, Hematology and Medical Oncology, Assistant Professor, Oncological Sciences, Mount Sinai School of Medicine, Derald H. Ruttenberg Treatment Center, New York, NY

George Simon, MD Director, Thoracic Oncology, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA

Sandeep Soni, MD Pediatric Blood and Bone Marrow Transplant Program, Hematology/Oncology, Nationwide Children’s Hospital, Columbus, Ohio

Juan W. Valle, MD Senior Lecturer and Medical Oncologist, University of Manchester, Christie Hospital, Manchester, England, UK

Rav Vij, MD  Assistant Professor, Department of Medicine, Oncology Division, Bone Marrow Transplantation and Leukemia Section, Washington University Medical School, St. Louis, MO

Daniel Von Hoff, MD, FACP Physician In Chief, Senior Investigator, Director, Clinical Translational Research Division, Clinical Professor of Medicine, University of Arizona, Department of Medicine, Phoenix, AZ

David Walterhouse, MD Associate Professor of Pediatrics, Northwestern University's Feinberg School of Medicine, Children’s Memorial Medical Center, Chicago, IL

Leonard Wexler, MD.Associate Professor of Clinical Pediatrics at Weill College of Medicine of Cornell University, Associate Attending Pediatrician, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, Chief, Soft Tissue Sarcoma Section, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY

Naomi Winick, MD Professor, Pediatric Hematology-Oncology, Southwestern Medical Center, Dallas, TX

Norman Wolmark, MD Chairman, NSABP, Chairman, Department of Human Oncology, Professor of Human Oncology, Drexel University College of Medicine, Philadelphia, PA

John J. Wright, MD, PhD Associate Branch Chief, Investigational Drug Branch, CTEP, DCTD, NCI, NIH, Bethesda, MD

James C. Yao, MD Associate Professor and Deputy Chairman, Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX

Peter Paul Yu, MD Director, Cancer Research, Palo Alto Medical Foundation, Chair, Electronic Health Record Work Group, American Society of Clinical Oncology, Palo Alto, CA

Jasmine Zain, MD, Director, Bone Marrow Transplant Program, Assistant Professor, Division of Hematologic Malignancies and Medical Oncology, NYU Langone Medical Center, New York, NY

Theoklis Zaoutis MD, Attending Physician, Children’s Hospital of Philadelphia, PA

 

© 2010 The Chemotherapy Foundation - All Rights Reserved